Symbol="RYTM"
AssetType="Common Stock"
Name="Rhythm Pharmaceuticals Inc"
Description="Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of rare genetic diseases of obesity. The company is headquartered in Boston, Massachusetts."
CIK="1649904"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1002920000"
EBITDA="-177218000"
PERatio="None"
PEGRatio="None"
BookValue="3.865"
DividendPerShare="0"
DividendYield="0"
EPS="-3.38"
RevenuePerShareTTM="0.626"
ProfitMargin="0"
OperatingMarginTTM="-5.33"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-0.793"
RevenueTTM="33609000"
GrossProfitTTM="21505000"
DilutedEPSTTM="-3.38"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.66"
AnalystTargetPrice="37"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="95.69"
PriceToBookRatio="5.01"
EVToRevenue="63.85"
EVToEBITDA="-3.718"
Beta="1.684"
num_52WeekHigh="34.99"
num_52WeekLow="11.72"
num_50DayMovingAverage="17.12"
num_200DayMovingAverage="22.39"
SharesOutstanding="56855000"
DividendDate="None"
ExDividendDate="None"
symbol="RYTM"
open="17.64"
high="17.93"
low="17.47"
price="17.64"
volume="724917.00"
latest_trading_day="2023-07-26"
previous_close="17.73"
change="-0.09"
change_percent="-0.5076%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="705862"
Change_recent_avg="-0.04"
Delta_recent_avg="0.95"
Variance_recent_avg="0.48"
Change_ratio_recent_avg="-0.27"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="502"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0103.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
